Tag: EXCiPACT

Desert King® Becomes First Chilean Company to Earn EXCiPACT™ Certification, Cementing Global Leadership in Vaccine Adjuvant Production

April 24, 2025

Desert King®, a global leader in Quillaja saponaria-based vaccine adjuvants, has secured EXCiPACT™ certification for its Chilean pharmaceutical facility, becoming the first Chilean company and only global Quillaja supplier to…
Read More

Categories

Latest Posts

Good news! As the exclusive agent of Desert King in China, our company has successfully completed the agency application for the registration of its product, the pharmaceutical excipient Quillaja saponin QS-21, and it has now entered Public Notice Phase I!

September 2, 2025
Desert King® Becomes First Chilean Company to Earn EXCiPACT™ Certification, Cementing Global Leadership in Vaccine Adjuvant Production

April 24, 2025
QS-21: A Potent Vaccine Adjuvant

April 23, 2025
The Second Online Scientific Forum on Novel Vaccine Adjuvants

April 19, 2025
The DesertKing producing QS-21 and Vet-Sap became the excipients company certified by IPEC GMP

November 26, 2024

Recent Comments

No comments to show.

Tags

EXCiPACT, GMP, Quillaja

Accessibility Adjustments

Powered by OneTap

Colors

Orientation